UniqueFlow Ltd.

www.uniqueflow.com

High-Tech Company

Suspended Operations Q2/2015

TECH VERTICALS

Healthtech, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Initial Revenues
Established	2004
Number of Employees	2
Reg. Number:	abCDe

DESCRIPTION

UniqueFlow is developing miniaturized innovative drug delivery systems for controlled release of medications such as insulin, hydro-morphine, hormones etc. UniqueFlow’s first product, UniquePatch, is an active patch especially suitable (thus not confined) to continuous subcutaneous insulin infusion (CSII). It is based on novel patent-pending mechanism incorporating both Piezoelectric and MEMS technologies. This small insulin delivery system is beneficial for both health insurance firms and patients, enabling more diabetes patients gain access and adopt this clinically superior CSII-based diabetes treatment.

TECHNOLOGY

UniquePatch system sets new standards for miniaturization of continuous subcutaneous insulin delivery systems - it is about quarter of both volume and weight compared to existing products, making it much easier to conceal on the body by the end-users. This patent-pending technology results also in an extremely low system cost thus simplifying market penetration.

Nevertheless, no compromise on performance is made: the product is reliable, durable, fits mass-production and exhibits high accuracy and very low power consumption. Much emphasis is put on safety by including various fail-safe and monitoring mechanisms to ensure correct dosage such as patented pressure sensor monitoring the insulin pressure and sensitive reservoir volume sensor.

Products and Phases

Product	Phase
UniquePatch
UniquePatch is an active patch especially suitable (thus not confined) to continuous subcutaneous insulin infusion (CSII) system. It is based on novel patent-pending mechanism incorporating both Piezoelectric and MEMS technologies.

	TARGET MARKETS
	Medical equipment manufacturers / distributors, Health insurance firms, Diabetes and Pain relief health clinics and patients.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	42 Groniman St., Ramat Aviv
City	Tel Aviv
Country	Israel
Zip	6997248

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Shaul Ozeri	CEO & Co-Founder
Dr. Jonathan Ozeri	Director of Clinical Affairs, Co-Founder

Last Updated:	abCDe
IVC Number:	abCDe